Venus Concept INC 8-K filings

Venus Concept Inc. obtains a $2.3 million drawdown under its loan agreement and announces the resignation of its President and COO, Hemanth Varghese, effective March 28, 2025.

Venus Concept Inc. stockholders approved a reverse stock split at a ratio between 5:1 and 16:1 during a special meeting held on February 14, 2025.

Venus Concept amends its loan agreement with Madryn Health Partners, increasing the delayed draw commitment to $11 million and extending the maturity date to February 28, 2025, while also gaining relief on certain liquidity requirements.

Venus Concept Inc. has entered into a Consent Agreement and a Tenth Bridge Loan Amendment to address liquidity requirements and extend the maturity date of its bridge financing.

Venus Concept Inc. has amended its loan agreements to defer payments and increase borrowing capacity, while also announcing the resignation of a board member.

Venus Concept's third-quarter revenue fell short of estimates, but the company made progress in reducing debt and operational costs.

Venus Concept has obtained a $1 million bridge loan drawdown and secured a waiver for certain liquidity requirements, while also extending the maturity date of its bridge financing.

Venus Concept has extended the deadline for completing a strategic transaction, which would trigger bonus payments for key employees, by an additional 12 months to September 30, 2025.

Venus Concept exchanged $15 million of senior debt for preferred stock, further reducing its debt obligations.

Venus Concept Inc. has drawn down an additional $1 million under its existing bridge loan agreement for general working capital purposes.

Venus Concept has entered into a Consent Agreement providing relief on liquidity requirements and allowing for payment-in-kind interest, while also extending the maturity date of its bridge loan.

Venus Concept's Q2 2024 results show a revenue decrease of 17% year-over-year, but also a significant reduction in cash used in operations and improved gross margins.

Venus Concept Inc. has obtained a $1 million bridge loan drawdown and amended its loan agreements to provide financial flexibility.

Venus Concept Inc. has entered into agreements with Madryn Health Partners to amend loan terms and extend the maturity date of a bridge loan.

Venus Concept Inc. has amended its loan agreements with Madryn Health Partners, securing waivers on liquidity requirements and extending debt maturities.

Venus Concept Inc. has obtained relief from minimum liquidity requirements and extended the maturity date of its bridge loan, providing short-term financial flexibility.

Venus Concept Inc. has been notified by Nasdaq that it has regained compliance with the stockholders' equity requirement, resolving a previous listing issue.

Venus Concept has amended its previous 8-K filing to correct the amount of debt exchanged and the description of the new notes issued in a transaction with Madryn Health Partners.

Venus Concept has significantly reduced its debt by $35 million through an exchange with Madryn Asset Management for newly created Series Y preferred stock.

Venus Concept reported a 15% year-over-year revenue decrease to $17.5 million for the first quarter of 2024, but exceeded its own estimate by $1 million.

Venus Concept Inc. has entered into a loan agreement with Madryn Health Partners for up to $5 million in bridge financing to cover short-term obligations.

Venus Concept Inc. has been notified by Nasdaq that its stock price has fallen below the minimum bid price requirement for continued listing.

Venus Concept announced its fiscal year 2023 results, highlighting a significant reduction in cash burn and strategic restructuring efforts despite a decrease in overall revenue.

Venus Concept has been granted an extension to maintain its Nasdaq listing, contingent on meeting specific financial requirements by May 28, 2024.

Venus Concept has successfully completed a registered direct offering and concurrent private placement, raising approximately $1.2 million.

Venus Concept Inc. has approved transaction completion bonuses for key executives, contingent on a successful strategic transaction.

Venus Concept's Board of Directors has begun evaluating strategic alternatives, including potential financings, mergers, and asset sales, to enhance shareholder value.

Venus Concept has obtained $2 million in secured convertible notes from EW Healthcare Partners to bolster its financial position and support strategic objectives.